Your email has been successfully added to our mailing list.

×
0 0 0.00201238390092869 0.00335397316821454 -0.00386996904024782 -0.00288957688338498 -0.00154798761609913 -0.00482972136222921
Stock impact report

FDA tentatively OKs Perrigo's generic Onexton [Seeking Alpha]

VALEANT PHARMACEUTICALS (VRX) 
Last valeant pharmaceuticals earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: ir.valeant.com
Company Research Source: Seeking Alpha
FDA tentatively OKs Perrigo's generic OnextonThe FDAtentatively approves Perrigo's (PRGO-0.2%) generic version of Valeant Pharmaceuticals (VRX-1.8%) unit Ortho Dermatologics' ONEXTON Gel (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%) for the topical treatment of acne vulgaris in patients at least 12 years old.Tentative approval means that the marketing application met the standards for approval but patent issues need to be resolved, although the company says it settled patent litigation with Valeant and Dow Pharmaceutical Sciences.Click to subscribe to real-time analytics on PRGONow read:Valeant: I Was Serious - The Clock Is Ticking » Show less Read more
Impact Snapshot
Event Time:
VRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VRX alerts
Opt-in for
VRX alerts

from News Quantified
Opt-in for
VRX alerts

from News Quantified